SpectraCure at Stora Aktiedagen in Gothenburg

Masoud Khayyami VD SpectraCure

A new opportunity to listen to Masoud Khayyami, CEO of SpectraCure, will be at Stora Aktiedagen in  Gothenburg November 4th. 

The SpectraCure Company presentation, including the status of current clinical study, will be held at 1.30 p m. The event will be streamed at  www.aktiespararna.se/tv/live.

Where:  Hall G3, Svenska Mässan, Mässans Gata 24, Gothenburg


For further information, contact:

SpectraCure AB publ, CEO, Masoud Khayyami, phone: +46(0) 70 815 21 90

Certified Adviser is G&W Fondkommission, e-mail: ca@gwkapital.se, phone: +46-(8)-503 000 50.

SpectraCure in short
SpectraCure was founded in 2003 as a spin off from Lund University departments for medical laser applications and physics. The company focuses on cancer treatments using medical systems with laser light sources and reactive drugs, which is referred to as "Interstitial Photodynamic Therapy", PDT, a treatment methodology suitable for internal solid tumours of various kind, e.g. prostate and abdominal salivary glands, but also other indications such as cancer tumours in the head and neck region.


About Us

SpectraCure's business concept is to, with its proprietary and patent-pending system, cure internal cancer tumors, prolong survival for cancer patients, and to act as complementary treatment options for other cancer treatments.




Documents & Links

Quick facts

A new opportunity to listen to Masoud Khayyami, CEO of SpectraCure, will be at Stora Aktiedagen in Gothenburg November 4th at 1.30 pm. The event will be live-streamed.
Tweet this